EMBCV Stock Price, Chart, Stats & News

Embecta Corp.
Save
1.91B
Market cap
–
Current P/E
–
Forward P/E
EMBCV chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.11% |
Operating margin | 27.48% |
Pretax margin | 18.14% |
Net margin | 12.92% |
Effective tax rate | 28.79% |
ROA | 13.11% |
ROE | -27.59% |
D/E | -2.27x |
Interest coverage ratio | -2.87x |
EMBCV valuation
P/E | – |
P/S | 1.77x |
P/B | – |
P/CF | – |
P/FCF | 19.60x |
P/OCF | – |
PEG | – |
EV multiple | 2.41x |
About
Embecta Corp. operates as a medical device company, primarily dedicated to improving the health and overall well-being of individuals living with diabetes. Its diverse product range encompasses essential items like pen needles, syringes, and various safety devices, alongside digital tools specifically designed to assist with diabetes self-management. The company distributes its offerings mainly through wholesalers and distributors, reaching customers across the United States and internationally.
Similar securities
Based on sector and market capitalization
Report issue











